Advance of promising targets and agents against COVID-19 in China.
Identifieur interne : 001A56 ( Main/Corpus ); précédent : 001A55; suivant : 001A57Advance of promising targets and agents against COVID-19 in China.
Auteurs : Yongtao Duan ; Hai-Liang Zhu ; Chongchen ZhouSource :
- Drug discovery today [ 1878-5832 ] ; 2020.
English descriptors
- KwdEn :
- Adenine (analogs & derivatives), Adenine (therapeutic use), Adenosine Monophosphate (analogs & derivatives), Adenosine Monophosphate (therapeutic use), Alanine (analogs & derivatives), Alanine (therapeutic use), Amides (therapeutic use), Antimalarials (therapeutic use), Antiviral Agents (therapeutic use), Betacoronavirus (metabolism), COVID-19 (MeSH), China (MeSH), Chloroquine (therapeutic use), Clinical Trials as Topic (MeSH), Cobicistat (therapeutic use), Coronavirus 3C Proteases (MeSH), Coronavirus Infections (drug therapy), Cysteine Endopeptidases (metabolism), Dibenzothiepins (MeSH), Drug Combinations (MeSH), Drug Discovery (MeSH), Drug Therapy, Combination (MeSH), Emtricitabine (therapeutic use), Humans (MeSH), Hydroxychloroquine (therapeutic use), Indoles (therapeutic use), Lopinavir (therapeutic use), Medicine, Chinese Traditional (MeSH), Morpholines (MeSH), Oseltamivir (therapeutic use), Oxazines (therapeutic use), Pandemics (MeSH), Pneumonia, Viral (drug therapy), Pyrazines (therapeutic use), Pyridines (therapeutic use), Pyridones (MeSH), RNA-Dependent RNA Polymerase (metabolism), Ritonavir (therapeutic use), SARS-CoV-2 (MeSH), Spike Glycoprotein, Coronavirus (metabolism), Tenofovir (therapeutic use), Thiepins (therapeutic use), Triazines (therapeutic use), Viral Nonstructural Proteins (metabolism).
- MESH :
- chemical , analogs & derivatives : Adenine, Adenosine Monophosphate, Alanine.
- chemical , metabolism : Cysteine Endopeptidases, RNA-Dependent RNA Polymerase, Spike Glycoprotein, Coronavirus, Viral Nonstructural Proteins.
- chemical , therapeutic use : Adenine, Adenosine Monophosphate, Alanine, Amides, Antimalarials, Antiviral Agents, Chloroquine, Cobicistat, Emtricitabine, Hydroxychloroquine, Indoles, Lopinavir, Oseltamivir, Oxazines, Pyrazines, Pyridines, Ritonavir, Tenofovir, Thiepins, Triazines.
- geographic : China, Coronavirus 3C Proteases, Dibenzothiepins, Drug Combinations, Morpholines, Pyridones.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- metabolism : Betacoronavirus.
- COVID-19, Clinical Trials as Topic, Drug Discovery, Drug Therapy, Combination, Humans, Medicine, Chinese Traditional, Pandemics, SARS-CoV-2.
DOI: 10.1016/j.drudis.2020.02.011
PubMed: 32198066
PubMed Central: PMC7102657
Links to Exploration step
pubmed:32198066Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Advance of promising targets and agents against COVID-19 in China.</title>
<author><name sortKey="Duan, Yongtao" sort="Duan, Yongtao" uniqKey="Duan Y" first="Yongtao" last="Duan">Yongtao Duan</name>
<affiliation><nlm:affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zhu, Hai Liang" sort="Zhu, Hai Liang" uniqKey="Zhu H" first="Hai-Liang" last="Zhu">Hai-Liang Zhu</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, China. Electronic address: zhuhl@nju.edu.cn.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zhou, Chongchen" sort="Zhou, Chongchen" uniqKey="Zhou C" first="Chongchen" last="Zhou">Chongchen Zhou</name>
<affiliation><nlm:affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China. Electronic address: zhouchongchen@163.com.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32198066</idno>
<idno type="pmid">32198066</idno>
<idno type="doi">10.1016/j.drudis.2020.02.011</idno>
<idno type="pmc">PMC7102657</idno>
<idno type="wicri:Area/Main/Corpus">001A56</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001A56</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Advance of promising targets and agents against COVID-19 in China.</title>
<author><name sortKey="Duan, Yongtao" sort="Duan, Yongtao" uniqKey="Duan Y" first="Yongtao" last="Duan">Yongtao Duan</name>
<affiliation><nlm:affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zhu, Hai Liang" sort="Zhu, Hai Liang" uniqKey="Zhu H" first="Hai-Liang" last="Zhu">Hai-Liang Zhu</name>
<affiliation><nlm:affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, China. Electronic address: zhuhl@nju.edu.cn.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zhou, Chongchen" sort="Zhou, Chongchen" uniqKey="Zhou C" first="Chongchen" last="Zhou">Chongchen Zhou</name>
<affiliation><nlm:affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China. Electronic address: zhouchongchen@163.com.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Drug discovery today</title>
<idno type="eISSN">1878-5832</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenine (analogs & derivatives)</term>
<term>Adenine (therapeutic use)</term>
<term>Adenosine Monophosphate (analogs & derivatives)</term>
<term>Adenosine Monophosphate (therapeutic use)</term>
<term>Alanine (analogs & derivatives)</term>
<term>Alanine (therapeutic use)</term>
<term>Amides (therapeutic use)</term>
<term>Antimalarials (therapeutic use)</term>
<term>Antiviral Agents (therapeutic use)</term>
<term>Betacoronavirus (metabolism)</term>
<term>COVID-19 (MeSH)</term>
<term>China (MeSH)</term>
<term>Chloroquine (therapeutic use)</term>
<term>Clinical Trials as Topic (MeSH)</term>
<term>Cobicistat (therapeutic use)</term>
<term>Coronavirus 3C Proteases (MeSH)</term>
<term>Coronavirus Infections (drug therapy)</term>
<term>Cysteine Endopeptidases (metabolism)</term>
<term>Dibenzothiepins (MeSH)</term>
<term>Drug Combinations (MeSH)</term>
<term>Drug Discovery (MeSH)</term>
<term>Drug Therapy, Combination (MeSH)</term>
<term>Emtricitabine (therapeutic use)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Indoles (therapeutic use)</term>
<term>Lopinavir (therapeutic use)</term>
<term>Medicine, Chinese Traditional (MeSH)</term>
<term>Morpholines (MeSH)</term>
<term>Oseltamivir (therapeutic use)</term>
<term>Oxazines (therapeutic use)</term>
<term>Pandemics (MeSH)</term>
<term>Pneumonia, Viral (drug therapy)</term>
<term>Pyrazines (therapeutic use)</term>
<term>Pyridines (therapeutic use)</term>
<term>Pyridones (MeSH)</term>
<term>RNA-Dependent RNA Polymerase (metabolism)</term>
<term>Ritonavir (therapeutic use)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Spike Glycoprotein, Coronavirus (metabolism)</term>
<term>Tenofovir (therapeutic use)</term>
<term>Thiepins (therapeutic use)</term>
<term>Triazines (therapeutic use)</term>
<term>Viral Nonstructural Proteins (metabolism)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Adenine</term>
<term>Adenosine Monophosphate</term>
<term>Alanine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Cysteine Endopeptidases</term>
<term>RNA-Dependent RNA Polymerase</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Viral Nonstructural Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adenine</term>
<term>Adenosine Monophosphate</term>
<term>Alanine</term>
<term>Amides</term>
<term>Antimalarials</term>
<term>Antiviral Agents</term>
<term>Chloroquine</term>
<term>Cobicistat</term>
<term>Emtricitabine</term>
<term>Hydroxychloroquine</term>
<term>Indoles</term>
<term>Lopinavir</term>
<term>Oseltamivir</term>
<term>Oxazines</term>
<term>Pyrazines</term>
<term>Pyridines</term>
<term>Ritonavir</term>
<term>Tenofovir</term>
<term>Thiepins</term>
<term>Triazines</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>China</term>
<term>Coronavirus 3C Proteases</term>
<term>Dibenzothiepins</term>
<term>Drug Combinations</term>
<term>Morpholines</term>
<term>Pyridones</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>COVID-19</term>
<term>Clinical Trials as Topic</term>
<term>Drug Discovery</term>
<term>Drug Therapy, Combination</term>
<term>Humans</term>
<term>Medicine, Chinese Traditional</term>
<term>Pandemics</term>
<term>SARS-CoV-2</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32198066</PMID>
<DateCompleted><Year>2020</Year>
<Month>06</Month>
<Day>29</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1878-5832</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>25</Volume>
<Issue>5</Issue>
<PubDate><Year>2020</Year>
<Month>05</Month>
</PubDate>
</JournalIssue>
<Title>Drug discovery today</Title>
<ISOAbbreviation>Drug Discov Today</ISOAbbreviation>
</Journal>
<ArticleTitle>Advance of promising targets and agents against COVID-19 in China.</ArticleTitle>
<Pagination><MedlinePgn>810-812</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1359-6446(20)30098-2</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.drudis.2020.02.011</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Duan</LastName>
<ForeName>Yongtao</ForeName>
<Initials>Y</Initials>
<AffiliationInfo><Affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zhu</LastName>
<ForeName>Hai-Liang</ForeName>
<Initials>HL</Initials>
<AffiliationInfo><Affiliation>State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, China. Electronic address: zhuhl@nju.edu.cn.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zhou</LastName>
<ForeName>Chongchen</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou, 450018, China. Electronic address: zhouchongchen@163.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>03</Month>
<Day>18</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Drug Discov Today</MedlineTA>
<NlmUniqueID>9604391</NlmUniqueID>
<ISSNLinking>1359-6446</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000577">Amides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003988">Dibenzothiepins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007211">Indoles</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009025">Morpholines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010078">Oxazines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011719">Pyrazines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011725">Pyridines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011728">Pyridones</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013846">Thiepins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014227">Triazines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000613801">emtricitabine tenofovir alafenamide</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C558899">lopinavir-ritonavir drug combination</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000657845">spike protein, SARS-CoV-2</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>20O93L6F9H</RegistryNumber>
<NameOfSubstance UI="D053139">Oseltamivir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>2494G1JF75</RegistryNumber>
<NameOfSubstance UI="D061466">Lopinavir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>3QKI37EEHE</RegistryNumber>
<NameOfSubstance UI="C000606551">remdesivir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>415SHH325A</RegistryNumber>
<NameOfSubstance UI="D000249">Adenosine Monophosphate</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4G86Y4JT3F</RegistryNumber>
<NameOfSubstance UI="C000628402">baloxavir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>93M09WW4RU</RegistryNumber>
<NameOfSubstance UI="C086979">umifenovir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>99YXE507IL</RegistryNumber>
<NameOfSubstance UI="D000068698">Tenofovir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.7.48</RegistryNumber>
<NameOfSubstance UI="D012324">RNA-Dependent RNA Polymerase</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber>
<NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.22.28</RegistryNumber>
<NameOfSubstance UI="D000086782">Coronavirus 3C Proteases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EW5GL2X7E0</RegistryNumber>
<NameOfSubstance UI="C462182">favipiravir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>G70B4ETF4S</RegistryNumber>
<NameOfSubstance UI="D000068679">Emtricitabine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>JAC85A2161</RegistryNumber>
<NameOfSubstance UI="D000225">Adenine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>LW2E03M5PG</RegistryNumber>
<NameOfSubstance UI="D000069547">Cobicistat</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>O3J8G9O825</RegistryNumber>
<NameOfSubstance UI="D019438">Ritonavir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>OF5P57N2ZX</RegistryNumber>
<NameOfSubstance UI="D000409">Alanine</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000225" MajorTopicYN="N">Adenine</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000249" MajorTopicYN="N">Adenosine Monophosphate</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000409" MajorTopicYN="N">Alanine</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000577" MajorTopicYN="N">Amides</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000069547" MajorTopicYN="N">Cobicistat</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086782" MajorTopicYN="N">Coronavirus 3C Proteases</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003988" MajorTopicYN="N">Dibenzothiepins</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000068679" MajorTopicYN="N">Emtricitabine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007211" MajorTopicYN="N">Indoles</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D061466" MajorTopicYN="N">Lopinavir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008516" MajorTopicYN="N">Medicine, Chinese Traditional</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009025" MajorTopicYN="N">Morpholines</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053139" MajorTopicYN="N">Oseltamivir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010078" MajorTopicYN="N">Oxazines</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011719" MajorTopicYN="N">Pyrazines</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011725" MajorTopicYN="N">Pyridines</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011728" MajorTopicYN="N">Pyridones</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012324" MajorTopicYN="N">RNA-Dependent RNA Polymerase</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019438" MajorTopicYN="N">Ritonavir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000068698" MajorTopicYN="N">Tenofovir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013846" MajorTopicYN="N">Thiepins</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014227" MajorTopicYN="N">Triazines</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017361" MajorTopicYN="N">Viral Nonstructural Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>02</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>02</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>7</Month>
<Day>1</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>3</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32198066</ArticleId>
<ArticleId IdType="pii">S1359-6446(20)30098-2</ArticleId>
<ArticleId IdType="doi">10.1016/j.drudis.2020.02.011</ArticleId>
<ArticleId IdType="pmc">PMC7102657</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Science. 2020 Mar 13;367(6483):1260-1263</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32075877</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 22;395(10224):565-574</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32007145</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Feb 19;368:m606</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32075786</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2020 Mar 27;367(6485):1444-1448</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32132184</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A56 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001A56 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidChloroV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:32198066 |texte= Advance of promising targets and agents against COVID-19 in China. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32198066" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidChloroV1
![]() | This area was generated with Dilib version V0.6.38. | ![]() |